Bumper Offer - Urjas oil Just @ Rs. 1
Lartan Am is a commercial drug that is prescribed in the form of Tablet. Lartan Am also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Lartan Am. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Lartan Am can also lead to other problems, which have been listed below. These side effects of Lartan Am are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Lartan Am has a Severe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Lartan Am's effects on the liver, heart and kidney, if any, have been listed below.
Lartan Am is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease as it can result in adverse effects. Other conditions have been mentioned below in the Lartan Am contraindications section.
Besides this, Lartan Am may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Lartan Am is considered not safe while driving, and is not addictive.
Lartan Am is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Lartan Am is used -
Moderate
Mild
Is the use of Lartan Am safe for pregnant women?
Lartan Am can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Lartan Am safe during breastfeeding?
Lartan Am may have very limited harmful effects for breastfeeding women.
What is the effect of Lartan Am on the Kidneys?
There are no side effects of Lartan Am on the kidneys.
What is the effect of Lartan Am on the Liver?
Lartan Am has very mild side effects on the liver.
What is the effect of Lartan Am on the Heart?
Lartan Am is rarely harmful for the heart.
Lartan Am should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lartan Am unless your doctor advises you to do so -
Is this Lartan Am habit forming or addictive?
Lartan Am does not cause addiction.
Interaction between Food and Lartan Am
Taking Lartan Am with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Lartan Am
Consuming Lartan Am with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cozaar® (losartan potassium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 506
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
